NEW YORK (GenomeWeb News) – Lab21 will serve as exclusive distributor of AdnaGen's circulating tumor cell diagnostic assays in the UK and Ireland under an alliance announced today.

AdnaGen's AdnaTest products detect and analyze circulating tumor cells from metastatic breast cancer and metastatic colon cancer. According to the firms, AdnaGen's tests enable detection of a broad range of tumor molecular markers.

Cambridge, UK-based Lab21 said that it expects to launch the tests as a service beginning in October.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.